Clinical
or haematogenously to cause menin-
goencephalitis.4,6 The disease may also
disseminate via blood or lymphatics to
other tissues including lymph nodes,
skin, lung and kidney.6-7 Concurrent
upper and lower respiratory tract disease
without systemic dissemination, as seen
in this case, has rarely been described. 8
Cryptococcal infections in cats may be
treated with oral triazole drugs including
fluconazole and itraconazole, either
alone or in combination with ampho-
tericin B and flucytosine.4,5 Treatment
using azole drugs alone takes months to
years to effect a cure and concurrent FIV
infection may necessitate longer courses
of therapy.9 Itraconazole may cause
reversible, dose-related, hepatotoxicity
in cats10 as in the present case, although
a 50% reduction in the dosage usually
permits therapy to be continued.
Serology is a useful noninvasive method
of monitoring efficacy of therapy.
Ideally, antifungal therapy should be
continued until the LCAT titre declines
to less than 1.10,11
It is well established that immune
dysfunction, usually resulting from HIV
infection, is a major predisposing factor
for the development of cryptococcosis in
humans .12 Whether the same is true in
cats remains the subject of debate. The
prevalence of FIV infection in cats with
cryptococcosis in Australia has been
reported by Malik et al to be 28%.9
Since this prevalence approximated that
reported among healthy cats in
Australia13 it was interpreted as indi-
cating that FIV-positivity is not a signifi-
cant risk factor for the development of
cryptococcosis. However, subsequent
seroprevalence surveys from the same
region as cats studied by Malik et al
indicated that only 8% of healthy cats
are FIV-positive.14 Although FIV-
infection does not impart an
unfavourable prognosis, affected cats
tend to have advanced and/or dissemi-
nated disease.9,15 It is possible that FIV
infection in this cat was associated with
immune dysfunction manifested clini-
cally as sequential infections including
cryptococcosis, capillariasis and prob-
able viral upper respiratory tract disease.
Quantification of lymphocyte subsets or
viral load may have clarified whether the
cat had an AIDS-like status associated
with long-standing FIV infection.
However, lymphocyte subset numbers
may not be useful as a marker of
immune-dysfunction in FIV-infected
cats since impaired lymphocyte respon-
siveness precedes the decline in CD4 cell
counts and some chronically infected
cats have very low CD4 counts without
obvious clinical immunodeficiency.16-17
In this cat, impaired T-cell immunity
due to FIV infection may have been
associated with an increased propensity
to heavy parasitism by C aerophila and
subsequent development of bronchitis.
The role of T-cell mediated immunity in
nematode infections is well documented
and involves a strong T-helper2 cell-
mediated response.18
Capillaria aerophila and Aeluro-
strongylus abstrusus are nematode lung-
worms that may infect cats. A similar
prevalence (3-5%) has been reported
for both in surveys of Australian cats.19-21
C aerophila, a parasite of foxes, dogs and
cats, most commonly causes subclinical
infections. Clinical disease was common
in foxes farmed for fur where it was asso-
ciated with poor husbandry practices.22
In cats, clinical infections are reportedly
rare but, like A abstrusus, heavy worm
burdens may result in severe bronchitis
sometimes with secondary broncho-
pneumonia.23-27
C aerophila belongs to the family
Trichuridae. The double-operculated
ova of C aerophila may be mistaken for
Trichuris spp when found in faecal
preparations from cats, although they
are smaller (usually less than 70 mm
long), have radial striations and their
asymmetric bipolar plugs are less protru-
berant.23 The life cycle of C aerophila is
direct, although earthworms and
rodents may act as paratenic hosts. Adult
worms reside beneath the epithelium of
trachea, bronchi and bronchioles. In
dogs, C aerophila has been reported to
occur also in the frontal sinuses and
nasal cavity, although, in retrospect
these nematodes were likely mistaken for
C böhmi, a parasite of the frontal sinus
mucosae of the fox, that can be distin-
guished from C aerophila by their ova
which have pitted rather than striated
surfaces.22,28-30
C aerophila ova are shed into the
airways, coughed up, swallowed and
passed in faeces. Infective larvae develop
within the egg and may survive harsh
environments for up to 1 year. Ingested
ova hatch in the intestine and larvae
migrate haematogenously to the lungs
within a week. The prepatent period is 6
weeks and infections remain patent for 8
to 11 months.23 Specific treatment
protocols have not been evaluated but
fenbendazole, levamisole and ivermectin
have been used successfully. Avermectins
are effective for treatment of A abstrusus
infections and appear to be effective in
the treatment of C aerophila infections
in cats at a dose of 300 mg/kg. 30
Allergic bronchitis is the most
common cause of chronic coughing in
cats.31 This case shows that therapeutic
trials with corticosteroids for this condi-
tion should be undertaken with caution
since infectious agents or parasites may
occasionally cause similar signs and
radiographic findings. Unguided BAL
followed by cytological examination and
culture is a simple, cost-effective proce-
dure to facilitate differentiation of these
different disorders.
Acknowledgments
JA Beatty is supported by a Research
Career
Development
Fellowship
awarded by the Wellcome Trust, UK.
Richard Malik is supported by the
Valentine Charlton Bequest adminis-
tered by the Post Graduate Foundation
in Veterinary science of The University
of Sydney.
References:
1.Farrow CS. The thorax. In: Farrow CS, Green R,
Shively M, editors. Radiology of the cat. Mosby, St
Louis, 1994;74.
2. Lautenslager JP. Internal helminths of cats. Vet
Clin North Am 1976;6:353-362.
3. Malik R, Martin P, Wigney DI et al.
Nasopharyngeal cryptococcosis. Aust Vet
J
1997;75:483-488.
4. Malik R, Martin P, Wigney DI, Love DN.
Cryptococcosis in cats: diagnosis and treatment.
In: Feline practice. University of Sydney
Postgraduate Committee in Veterinary Science
Proceedings No 243 1995;49-54.
5. Malik R, Wigney DI, Muir DB et al.
Asymptomatic carriage of Cryptococcus neofor -
mans in the nasal cavity of dogs and cats. J Med
Vet Mycol 1997:35;27-31.
6. Jacobs GJ, Medleau L. Cryptococcosis. In:
Greene CE, editor. Infectious diseases of the dog
and cat. 2nd edn, Saunders, Philadelphia,
1998;383-390.
7. Hamilton TA, Hawkins EC, DeNicoa DB.
Bronchoalveolar lavage and tracheal wash to
determine lung involvement in a cat with crypto-
coccosis. J Am Vet Med Assoc 1991;198:655-656.
8. Jacobs GJ, Greene CE, Medleau L. Feline and
canine cryptococcosis. Waltham Focus 1998;8:21-
27.
9. Malik R, Wigney DI, Muir DB, Gregory DJ, Love
DN. Cryptococcosis in cats:clinical and mycolog-
ical assessment of 29 cases and evaluation of
treatment using orally administered fluconazole. J
Med Mycol 1992;30:133-44.
10. Medleau L, Jacobs GJ, Marks MA.
Itraconazole for the treatment of cryptococcosis in
cats. J Vet Intern Med 1995;9:39-42.
11. Malik R, McPetrie R, Wigney DI, Craig AJ,
Love DN. A latex cryptococcal antigen agglutina-
tion test for diagnosis and monitoring of therapy for
cryptococcosis. Aust Vet J 1996;74:358-364.
12. Mitchell TG, Perfect JR. Cryptococcosis in the
era of AIDS - 100 years after the discovery of
Cryptococcus neoformans. Clin Microbiol Rev
1995;8:515-548.
Aust Vet J Vol 78, No 3, March 2000
157